We are live on ! Find out more
KZIA icon

Kazia Therapeutics
KZIA

9 hedge funds and large institutions have $400K invested in Kazia Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,581% more capital inflows, than outflows

Capital inflows: $416K | Capital outflows: $24.7K

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

50% more funds holding

Funds holding: 6 → 9 (+3)

0.87% more ownership

Funds ownership: 0.8% → 1.67% (+0.87%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Transform Wealth
Transform Wealth
Colorado
+$361K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$37.7K
3
Morgan Stanley
Morgan Stanley
New York
+$15K
4
Steward Partners Investment Advisory
Steward Partners Investment Advisory
New York
+$1.87K
5
Fifth Third Bancorp
Fifth Third Bancorp
Ohio
+$170

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$19.4K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4K
3
UBS Group
UBS Group
Switzerland
-$1.36K

KZIA Hedge Fund Activity: Q3 2018 in Review

9 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2018, worth a combined $400K — up 27% from $314K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new KZIA positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Transform Wealth, opening a new position worth an estimated $361K. The largest seller was Acadian Asset Management, cutting an estimated $19.4K.

  • 9 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2018, up from 6 in Q2 2018.
  • Funds reported $400K of Kazia Therapeutics stock for Q3 2018, up 27% quarter-over-quarter.
  • 4 funds opened new Kazia Therapeutics positions in Q3 2018 and 1 closed out, a net change of +3 holders.
  • The largest Kazia Therapeutics buyer in Q3 2018 was Transform Wealth, an estimated $361K added.
  • The largest Kazia Therapeutics seller in Q3 2018 was Acadian Asset Management, an estimated $19.4K sold.

Based on aggregated 13F filings for Q3 2018.